There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
Sickle Cell Disease: Shifting Paradigms in Optimal Management for NPs
Credit(s):
1.17 Contact Hour(s) of CE; 0.33 of which may be applied towards Pharmacology
Released: 12/11/2024 Expires: 12/31/2025 11:55 PM CT (subject to change)
CE for this activity will not be available after this date.
This activity includes transcription.
Overview: Sickle cell disease is a condition of immense and multifarious clinical gravity causing acute pain, joint damage, anemia, and risk of infection, stroke, delayed growth in children and adolescents, as well as long-term organ dysfunction. However, recent evolutions in treatment options offer promising novel and emerging therapeutics poised to truly revolutionize sickle cell disease care. In this edition of NP Pulse, NP specialists Sheryl Mitchell and Dr. Artangela Henry will guide NPs to diagnose and optimally manage sickle cell disease utilizing a patient-centric, evidence-driven approach to mitigate complications and improve quality-of-life.
This activity is an Accredited AANP Podcast Activity. Learners will need to listen to the podcast through their preferred podcast provider (Search for "NP Pulse" and listen to Episode 133).A participation code will be given at the END of the podcast - make sure to write this code down. Once you've listened to the podcast and have the participation code, return to this activity in the CE Center. Click on the "Next Steps" button of the activity and (1) enter the participation code that was provided, (2) complete the post-test, and (3) complete the activity evaluation. This will award your CE credit and certificate of completion.
Objectives
Describe the epidemiologic patterns, pathophysiologic principles, and robust patient burden of sickle cell disease (SCD).
Examine current best practices for SCD diagnosis, highlighting the fundamental importance of early disease detection, characterization, and linkage to treatment.
Evaluate the established and evolving therapeutic landscape for SCD, with a focus on recent regulatory approvals and emerging trial data for novel agents.
Design individualized, evidence-driven treatment plans for patients with SCD that mitigate disease complications and improve quality-of-life.
Identify residual unmet needs in the SCD treatment paradigm and discuss the role of ongoing research and comprehensive, multidisciplinary care strategies in closing these gaps.
Speakers Artangela Henry, DNP, APRN, AGACNP-BC, FNP-C Sheryl Mitchell, DNP, APRN, FNP-BC, ACNP-BC, FAANP Disclosure This program was planned in accordance with AANP CE Standards and Policies.
The speakers for this activity have the following disclosures:
Artangela is on the Speakers Bureau for Pfizer and Emmaus LifeSciences.
Sheryl is on the advisor board for Astellas.
All relevant financial relationships have been mitigated. This program was funded by an educational grant from Vertex Pharmaceuticals, Inc.
Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content:
AANP Podcast: Click the Play button to be taken to the NP Pulse podcast on Podbean. If you have a different podcast provider that you prefer, launch your preferred podcast app and search for "NP Pulse".
Listen to all of Episode 133. A participation code will be provided at the end. Make sure to write this code down! You will need this code to unlock access the the post-test and evaluation to complete the activity to earn your CE credit. The code will consist of a LETTERS and NUMBERS. When entering the code in the Participation Code field, make sure you enter the letters and numbers together (no space between them). Letters are not case sensitive.
Return to the AANP CE Center. Click on the activity from your CE Activities list and then click the blue Next Steps button:
A new window will open. Provide and submit the Participation Code, exactly as it was given at the end of the podcast, in the available text field.
Complete the post-test.
Submit the activity evaluation to receive full AANP CE/Rx credit and your certificate of completion.
Additional Information For questions or more information concerning this online CE activity,please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.17 Contact Hour(s) of CE, 0.33 of which may be applied towards Pharmacology
Adding Registration, Please wait...
